Analyzing tiny particles from cells for better diagnostics and therapies
High-Throughput High-Content Nanoscale Extracellular Vesicle Analysis
['FUNDING_SBIR_1'] · NUMENTUS TECHNOLOGIES INC. · NIH-11008373
This study is exploring a new way to look at tiny particles released by cells that can provide important clues about cancer and infections, with the goal of helping doctors find better ways to diagnose and treat patients.
Quick facts
| Phase | ['FUNDING_SBIR_1'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NUMENTUS TECHNOLOGIES INC. (nih funded) |
| Locations | 1 site (MENLO PARK, UNITED STATES) |
| Trial ID | NIH-11008373 on ClinicalTrials.gov |
What this research studies
This research focuses on extracellular vesicles (EVs), which are small particles released by cells that carry important biological information. The project aims to develop a new technology that can identify and analyze different types of EVs, particularly those related to cancer and bacterial infections, at a very detailed level. By using advanced imaging techniques, the researchers hope to distinguish between various subpopulations of EVs, which could lead to improved diagnostic tools and treatment options for patients. The approach involves examining the surface proteins of these particles to gather critical data from clinical samples.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with cancer or bacterial infections who may benefit from advanced diagnostic techniques.
Not a fit: Patients with conditions unrelated to cancer or bacterial infections may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnostics and targeted therapies for cancer and other diseases.
How similar studies have performed: Other research has shown promise in using similar high-throughput analysis techniques for studying extracellular vesicles, indicating potential for success in this approach.
Where this research is happening
MENLO PARK, UNITED STATES
- NUMENTUS TECHNOLOGIES INC. — MENLO PARK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FARIS, GREGORY W — NUMENTUS TECHNOLOGIES INC.
- Study coordinator: FARIS, GREGORY W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer cell line